Arrowhead Pharmaceuticals, Inc. (HDP1)
FSX
Real-time Data
06:00 AM
Day's Range
54.3252 wk Range
29.99Overview - HDP1 - Arrowhead Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
6.95B
P/E (Trailing)
‪45.26‬
P/E (Forward)
‪-120.12‬
PEG Ratio
‪5.70‬
Price / Sales (TTM)
‪12.13‬
Price / Book
‪20.06‬
EV / EBITDA
‪-39.50‬
Profitability
Profit Margin
‪-47.79%‬
Operating Margin
‪-226.02%‬
Return on Assets
‪-8.10%‬
Return on Equity
‪-55.20%‬
Ownership
Shares Outstanding
141.13M
Float
122.44M
Held by Insiders
‪3.65%‬
Held by Institutions
‪85.46%‬
Price stats
Beta
‪1.28‬
50-Day Avg
‪71.28‬
200-Day Avg
‪62.49‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - HDP1 - Arrowhead Pharmaceuticals, Inc.
Peers - HDP1 - Arrowhead Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- HDP1FSXArrowhead Pharmaceuticals, Inc.8.14BMarket Cap+51.68%52-week change45.26P/E (Trailing)‪-47.79%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - HDP1 - Arrowhead Pharmaceuticals, Inc.
About
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company that develops medicines for intractable diseases using RNA interference, a gene-silencing approach designed to reduce the production of disease-causing proteins. Arrowhead Pharmaceuticals focuses on therapeutic areas including cardiometabolic, liver,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
